Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS42001719EBVENSG00000146648.21protein_codingEGFRYesNo1956E7BSV0
P00533
Q504U8
TVIS10006549HBVENSG00000146648.21protein_codingEGFRYesNo1956E7BSV0
P00533
Q504U8
TVIS10008067HBVENSG00000146648.21protein_codingEGFRYesNo1956E7BSV0
P00533
Q504U8
TVIS10008068HBVENSG00000146648.21protein_codingEGFRYesNo1956E7BSV0
P00533
Q504U8
TVIS30003991HIVENSG00000146648.21protein_codingEGFRYesNo1956E7BSV0
P00533
Q504U8
TVIS30079115HIVENSG00000146648.21protein_codingEGFRYesNo1956E7BSV0
P00533
Q504U8
TVIS30087748HIVENSG00000146648.21protein_codingEGFRYesNo1956E7BSV0
P00533
Q504U8
TVIS30081211HIVENSG00000146648.21protein_codingEGFRYesNo1956E7BSV0
P00533
Q504U8
TVIS30081546HIVENSG00000146648.21protein_codingEGFRYesNo1956E7BSV0
P00533
Q504U8
TVIS30082146HIVENSG00000146648.21protein_codingEGFRYesNo1956E7BSV0
P00533
Q504U8
TCGA Plot Options
Drug Information
GeneEGFR
DrugBank IDDB09330
Drug NameOsimertinib
Target IDBE0000767
UniProt IDP00533
Regulation Typeinhibitor
PubMed IDs26522274; 34104899
CitationsYosaatmadja Y, Silva S, Dickson JM, Patterson AV, Smaill JB, Flanagan JU, McKeage MJ, Squire CJ: Binding mode of the breakthrough inhibitor AZD9291 to epidermal growth factor receptor revealed. J Struct Biol. 2015 Dec;192(3):539-44. doi: 10.1016/j.jsb.2015.10.018. Epub 2015 Nov 2.@@Vasconcelos PENS, Gergis C, Viray H, Varkaris A, Fujii M, Rangachari D, VanderLaan PA, Kobayashi IS, Kobayashi SS, Costa DB: EGFR-A763_Y764insFQEA Is a Unique Exon 20 Insertion Mutation That Displays Sensitivity to Approved and In-Development Lung Cancer EGFR Tyrosine Kinase Inhibitors. JTO Clin Res Rep. 2020 Sep;1(3). doi: 10.1016/j.jtocrr.2020.100051. Epub 2020 May 13.
GroupsApproved
Direct ClassificationN-alkylindoles
SMILESCOC1=C(NC2=NC=CC(=N2)C2=CN(C)C3=C2C=CC=C3)C=C(NC(=O)C=C)C(=C1)N(C)CCN(C)C
Pathways
PharmGKBPA166131626
ChEMBLCHEMBL3353410